|
Volumn 8, Issue 9, 1990, Pages 1483-1496
|
Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: Results from the national surgical adjuvant breast and bowel project B-15
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUOROURACIL;
METHOTREXATE;
TAMOXIFEN;
AGE;
ALOPECIA;
ARTICLE;
BREAST CANCER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LYMPH NODE METASTASIS;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOXORUBICIN;
FLUOROURACIL;
HUMANS;
METHOTREXATE;
MIDDLE AGED;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL ANALYSIS;
TAMOXIFEN;
|
EID: 0025063119
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.1990.8.9.1483 Document Type: Article |
Times cited : (556)
|
References (5)
|